Trial Profile
Erythropoietin in myocardial infarction
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Left ventricular dysfunction; Myocardial infarction
- Focus Pharmacodynamics
- Acronyms EPOMI
- 01 Feb 2012 Primary endpoint 'Myocardial-infarct-size' has not been met.
- 01 Feb 2012 Results published in the American Heart Journal.
- 28 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.